These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17330977)

  • 1. Type 2 diabetes and cardiovascular disease: reducing the risk.
    Bartels DW; Davidson MH; Gong WC
    J Manag Care Pharm; 2007 Mar; 13(2 Suppl A):S2-15; quiz S16-7. PubMed ID: 17330977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in All-Cause Health Care Utilization and Costs in a Type 2 Diabetes Mellitus Population with and Without a History of Cardiovascular Disease.
    Mehta S; Ghosh S; Sander S; Kuti E; Mountford WK
    J Manag Care Spec Pharm; 2018 Mar; 24(3):280-290. PubMed ID: 29485954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007-2017.
    Einarson TR; Acs A; Ludwig C; Panton UH
    Cardiovasc Diabetol; 2018 Jun; 17(1):83. PubMed ID: 29884191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic Burden of Cardiovascular Disease in Type 2 Diabetes: A Systematic Review.
    Einarson TR; Acs A; Ludwig C; Panton UH
    Value Health; 2018 Jul; 21(7):881-890. PubMed ID: 30005761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of cardiovascular events and vascular interventions in patients with type 2 diabetes.
    Engelen SE; van der Graaf Y; Stam-Slob MC; Grobbee DE; Cramer MJ; Kappelle LJ; de Borst GJ; Visseren FLJ; Westerink J;
    Int J Cardiol; 2017 Dec; 248():301-307. PubMed ID: 28802735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Markov model of the cost-effectiveness of pharmacist care for diabetes in prevention of cardiovascular diseases: evidence from Kaiser Permanente Northern California.
    Yu J; Shah BM; Ip EJ; Chan J
    J Manag Care Pharm; 2013 Mar; 19(2):102-14. PubMed ID: 23461426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin Resistance the Link between T2DM and CVD: Basic Mechanisms and Clinical Implications.
    Abdul-Ghani MA; Jayyousi A; DeFronzo RA; Asaad N; Al-Suwaidi J
    Curr Vasc Pharmacol; 2019; 17(2):153-163. PubMed ID: 29032755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early and intensive therapy for management of hyperglycemia and cardiovascular risk factors in patients with type 2 diabetes.
    Dailey G
    Clin Ther; 2011 Jun; 33(6):665-78. PubMed ID: 21704233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of Metabolic Syndrome by different definitions, and its association with type 2 diabetes, pre-diabetes, and cardiovascular disease risk in Brazil.
    do Vale Moreira NC; Hussain A; Bhowmik B; Mdala I; Siddiquee T; Fernandes VO; Montenegro Júnior RM; Meyer HE
    Diabetes Metab Syndr; 2020; 14(5):1217-1224. PubMed ID: 32682310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Framework to Understand the Progression of Cardiovascular Disease for Type 2 Diabetes Mellitus Patients Using a Network Approach.
    Hossain ME; Uddin S; Khan A; Moni MA
    Int J Environ Res Public Health; 2020 Jan; 17(2):. PubMed ID: 31963383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The management correlation between metabolic index, cardiovascular health, and diabetes combined with cardiovascular disease.
    Zhang Y; Liu C; Xu Y; Wang Y; Dai F; Hu H; Jiang T; Lu Y; Zhang Q
    Front Endocrinol (Lausanne); 2022; 13():1036146. PubMed ID: 36778594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors for Cardiovascular Disease Prevention.
    Reid J; Rana K; Niman S; Sheikh-Ali M; Lewis T; Choksi RR; Goldfaden RF
    Am J Cardiovasc Drugs; 2020 Oct; 20(5):419-429. PubMed ID: 32043244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing cardiovascular risk factors and selecting agents to successfully treat patients with type 2 diabetes mellitus.
    Baldwin MD
    J Am Osteopath Assoc; 2011 Jul; 111(7 Suppl 5):S2-12. PubMed ID: 21813732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus.
    Wilson PW; D'Agostino RB; Parise H; Sullivan L; Meigs JB
    Circulation; 2005 Nov; 112(20):3066-72. PubMed ID: 16275870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular event costs in patients with Type 2 diabetes mellitus.
    Johnston SS; Sheehan JJ; Shah M; Cappell K; Princic N; Smith D; Kalsekar I
    J Med Econ; 2015; 18(12):1032-40. PubMed ID: 26189723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. All-cause mortality and cardiovascular events in a Spanish nonagenarian cohort according to type 2 diabetes mellitus status and established cardiovascular disease.
    Salinero-Fort MA; Mostaza J; Lahoz C; Cárdenas-Valladolid J; Vicente-Díez JI; Gómez-Campelo P; de Miguel-Yanes JM
    BMC Geriatr; 2022 Mar; 22(1):224. PubMed ID: 35303825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Association Between Type 2 Diabetes and Cardiovascular Disease: The "For Your SweetHeart™" Survey.
    Perreault L; Boardman MK; Pak J
    Adv Ther; 2019 Mar; 36(3):746-755. PubMed ID: 30758740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of cardiovascular disease and risk factors in a type 2 diabetic population of the North Catalonia diabetes study.
    Jurado J; Ybarra J; Solanas P; Caula J; Gich I; Pou JM; Romeo JH
    J Am Acad Nurse Pract; 2009 Mar; 21(3):140-8. PubMed ID: 19302689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current trends in epidemiology of cardiovascular disease and cardiovascular risk management in type 2 diabetes.
    Yun JS; Ko SH
    Metabolism; 2021 Oct; 123():154838. PubMed ID: 34333002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-existing cardiovascular diseases and glycemic control in patients with type 2 diabetes mellitus in Europe: a matched cohort study.
    Fu AZ; Qiu Y; Radican L; Yin DD; Mavros P
    Cardiovasc Diabetol; 2010 Apr; 9():15. PubMed ID: 20409333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.